Johnson & Johnson

Johnson & Johnson ROE

The Return on Equity (ROE) of Johnson & Johnson (JNJ) as of Oct 30, 2026 is 32.87 %. In the previous year, Return on Equity (ROE) was 19.68 % — a change of 67.06% (higher).

ROE

32.87 %

YoY

67.06%

Last updated:

In 2025, Johnson & Johnson's return on equity (ROE) was 32.87 %, a 67.06% increase from the 19.68 % ROE in the previous year.

The Johnson & Johnson ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
25.60 USD
Jan 1, 2019
25.42 USD
Jan 1, 2020
23.25 USD
Jan 1, 2021
28.20 USD
Jan 1, 2022
23.36 USD
Jan 1, 2023
51.11 USD
Jan 1, 2024
19.68 USD
Jan 1, 2025
32.87 USD
The Johnson & Johnson ROE history
YEARROEYoY
32.87 %+67.06%
19.68 %-61.51%
51.11 %+118.81%
23.36 %-17.18%
28.20 %+21.30%
23.25 %-8.53%
25.42 %-0.70%
25.60 %+1,084.73%
2.16 %-90.80%
23.49 %+8.46%
21.66 %-7.45%
23.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Johnson & Johnson Stock analysis

What does Johnson & Johnson do? Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson is one of the most popular companies on Eulerpool.

ROE Details

Decoding Johnson & Johnson's Return on Equity (ROE)

Johnson & Johnson's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Johnson & Johnson's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Johnson & Johnson's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Johnson & Johnson’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Johnson & Johnson stock

Return on Equity (ROE) of Johnson & Johnson is 32.87 % in 2025.

Return on Equity (ROE) of Johnson & Johnson changed from 19.68 % to 32.87 %, representing a 67.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Johnson & Johnson since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Johnson & Johnson with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Johnson & Johnson

All Key Metrics — Johnson & Johnson